Browse the evidence

In obese adults, higher visceral adipose tissue (VAT) mass is independently associated with adverse metabolic, dyslipidemic, and atherogenic phenotypes, whereas abdominal subcutaneous adipose tissue (SAT) mass shows no independent association with these risks.

For obese individuals, total weight (BMI) is not the whole story. High visceral fat is strongly linked to heart disease and metabolic issues, even if subcutaneous fat is not. While MRI is not yet standard for everyone, this highlights the importance of targeting visceral fat reduction through lifestyle changes to lower cardiometabolic risk, rather than just focusing on total body weight.

High intramyocellular triacylglycerol (IMTG) content and high expression of fatty acid transporters (FAT/CD36) are associated with insulin resistance and type 2 diabetes, suggesting that lipid accumulation in muscle may contribute to the pathogenesis of insulin resistance.

If you have obesity or type 2 diabetes, high levels of fat stored within your muscle cells may contribute to insulin resistance. While this is not the case for all athletes, for the general population, reducing visceral and intramuscular fat through diet and exercise is crucial for restoring insulin sensitivity.

Elevated leptin levels in obesity disrupt the hypothalamic-pituitary-ovarian (HPO) axis, inhibiting folliculogenesis and oocyte maturation, thereby reducing fecundity.

High body fat leads to high leptin, which can disrupt your reproductive hormones and prevent ovulation. This is a biological response, not a failure of your body. Reducing body weight lowers leptin levels, which can help restore normal ovulation and improve your chances of conceiving.

Several months of heavy resistance training reduces central arterial compliance in healthy men, an effect that reverses upon detraining.

Heavy resistance training (high intensity, high volume) can reduce the elasticity of your central arteries. However, this study used a very intense protocol (80% 1RM to failure) that exceeds standard health guidelines. If you lift weights moderately, this specific risk may not apply, but be aware that extreme heavy lifting has distinct cardiovascular trade-offs compared to aerobic exercise.

Elevated circulating levels of Growth Differentiation Factor-15 (GDF-15) serve as a robust prognostic biomarker for cardiovascular mortality, heart failure severity, and all-cause mortality in patients with diabetes and cardiovascular diseases.

If you have diabetes or heart disease, ask your doctor about GDF-15 testing if it is available, as it may provide better risk stratification than standard markers alone. Focus on reducing the underlying stressors: manage blood glucose, control blood pressure, and reduce inflammation through lifestyle changes, as these factors drive GDF-15 elevation.

GDF-15 exhibits a dual role in cardiovascular health: it is cardioprotective against ischemia and hypertrophy via Smad and PI3K/AKT pathways, but its chronic elevation is associated with the progression of atherosclerosis and plaque instability.

Understanding GDF-15 helps explain why heart stress markers rise in disease. Managing cardiovascular risk factors (blood pressure, cholesterol, glucose) reduces the tissue stress that triggers GDF-15, potentially mitigating its negative long-term associations while allowing its protective acute effects to function.

In elderly men (aged 55+), higher endogenous levels of total and bioavailable testosterone are independently associated with a significantly lower risk of severe aortic atherosclerosis and slower progression of the disease.

For men over 55, maintaining healthy endogenous testosterone levels appears to be a key factor in preventing aortic atherosclerosis. While this study does not prescribe testosterone therapy, it highlights that low levels are a significant risk marker. Men concerned about heart health should discuss hormone levels with their doctor, especially if they experience symptoms of low testosterone, as restoring levels to a normal physiological range may be protective against vascular calcification.

In elderly women (aged 55+), higher endogenous testosterone levels are associated with a higher risk of severe aortic atherosclerosis, although this association is largely explained by adverse cardiovascular risk factors.

For women over 55, high testosterone levels are not protective against heart disease and may actually correlate with higher risk, primarily because high testosterone is linked to other negative health markers like higher blood pressure or cholesterol. Women should focus on managing traditional cardiovascular risk factors rather than assuming higher testosterone is beneficial.

Nonalcoholic fatty liver (NAFL) and significant liver disease, including cryptogenic cirrhosis, have a high prevalence (8.7% and 0.2% respectively) in nonobese, low-income populations in developing countries, driven by metabolic syndrome markers rather than general obesity.

If you live in or visit developing regions with limited healthcare, do not assume a normal or low BMI protects you from liver disease. Screen for metabolic markers like fasting glucose and liver enzymes, as fatty liver can develop due to insulin resistance even without excess body weight.

Abdominal obesity, dysglycemia, and higher income are independent risk factors for NAFL in nonobese populations, suggesting that metabolic dysfunction (insulin resistance) drives liver fat deposition more than general adiposity.

Monitor your waist circumference and blood sugar levels, not just your weight. In populations with lower average body weights, metabolic health markers like fasting glucose and waist size are better predictors of liver health than BMI alone.

High vulnerability to stress-related sleep disturbance (high FIRST scores) is associated with physiologic hyperarousal, evidenced by elevated sleep latency on the Multiple Sleep Latency Test (MSLT), even when excessive daytime sleepiness is excluded.

If you struggle with sleep, it might not just be about being tired. You may have a physiological 'hyperarousal' state where your body stays alert even when you want to sleep. This is a measurable trait, not just a habit. Managing stress and arousal levels is as important as sleep hygiene.

Overexpression of PGC1α in skeletal muscle reverses lipid-induced mitochondrial inefficiency by coupling incomplete fatty acid oxidation with complete oxidation, mimicking the metabolic benefits of exercise training.

Regular exercise naturally increases PGC1α levels in your muscles. This protein acts as a master switch that allows your mitochondria to burn fat completely and efficiently, even if you consume a high-fat diet. To mimic this benefit, prioritize consistent aerobic and resistance training to boost your muscle's metabolic flexibility and mitochondrial health.

Metformin treatment in type 2 diabetes patients significantly reduces the incidence of total, colorectal, liver, and pancreatic cancers, with effects observed at low doses (≤500 mg/day).

If you have Type 2 Diabetes and are taking metformin, this study suggests you may already be benefiting from a reduced risk of several cancers, including colorectal, liver, and pancreatic cancer, even at low doses (≤500 mg/day). Do not stop or change your medication without consulting your doctor, but be aware that your current treatment may offer protective benefits beyond blood sugar control.

Pioglitazone and Vitamin E are beneficial pharmacological interventions for non-diabetic NASH patients, and Pioglitazone improves fibrosis in diabetic patients.

For non-diabetic NASH, Pioglitazone or Vitamin E may be beneficial. For diabetic patients, Pioglitazone has been shown to reverse NASH and improve fibrosis. Consult a physician for prescription options.

The TyG-BMI index (Triglyceride Glucose index multiplied by Body Mass Index) is a superior predictor of insulin resistance compared to TyG index alone, TyG-WC, and TyG-WHtR in Korean adults.

If you are concerned about insulin resistance, ask your doctor for a fasting glucose and triglyceride test. You can calculate the TyG-BMI index yourself using your BMI. This combined metric is a highly accurate, low-cost way to screen for metabolic risk without needing complex or invasive procedures like a glucose clamp.

Klinefelter syndrome is associated with a significantly increased risk of metabolic syndrome, type 2 diabetes, and abdominal adiposity, independent of some socioeconomic factors.

Men with Klinefelter syndrome have a much higher risk of metabolic syndrome and diabetes than the general population. Regular screening for blood sugar, lipids, and waist circumference is essential, even if weight appears normal, due to the tendency for abdominal fat accumulation.

Acarbose extends median lifespan in male mice significantly more than in female mice, despite reducing body weight more in females.

Acarbose, a drug used to manage blood sugar spikes, significantly extends the lifespan of male mice, but has a much smaller effect on female mice. This benefit is not simply due to weight loss, as females lost more weight than males. This suggests that managing post-meal glucose spikes may have sex-specific longevity benefits, particularly for males.

Pharmacological activation of autophagy using mTOR inhibitors (e.g., rapamycin) or AMPK activators (e.g., metformin, AICAR) can extend lifespan and reduce inflammation in animal models.

Drugs like rapamycin and metformin can boost autophagy and extend lifespan in mice, but they have side effects in humans. Focus on lifestyle changes first, as they activate the same pathways safely.

Hypoxia in expanded white adipose tissue directly stimulates the expression and secretion of pro-inflammatory adipokines (e.g., IL-6, leptin, VEGF) and inhibits anti-inflammatory adiponectin, thereby driving the chronic inflammation associated with obesity.

This paper explains that as fat cells grow too large, they run out of oxygen (hypoxia), which triggers them to release inflammatory chemicals. This is a mechanical consequence of tissue expansion, not just 'bad diet'. While you cannot directly 'treat' hypoxia with a pill, reducing adipose tissue mass is the primary way to alleviate the physical crowding that causes this hypoxic inflammatory response.

Strenuous exercise induces menstrual disorders (amenorrhea or oligomenorrhea) in untrained women, primarily through energy deficiency and subsequent suppression of gonadotropin secretion.

If you are new to exercise, do not suddenly start exercising intensely while eating the same amount as before. Your body may stop ovulating if you create a large energy deficit. Ensure you eat enough to support your activity level to maintain menstrual health.

Testosterone deficiency, specifically low calculated free testosterone (cFT), is highly prevalent in men with type 1 diabetes (20.3%), contradicting the assumption that low testosterone is specific to type 2 diabetes.

Men with type 1 diabetes should be screened for low testosterone, as it is common (affecting ~1 in 5 men) and linked to insulin resistance, not just age.

Failure of adipose tissue to expand via new fat cell formation (proliferation/differentiation) forces excess lipid into ectopic sites (liver, skeletal muscle, pancreas), causing insulin resistance and type 2 diabetes.

Your body's ability to safely store fat in your fat cells is a key factor in your metabolic health. If your fat cells can't grow or multiply enough to handle your energy intake, fat spills over into your liver and muscles, causing insulin resistance. Focus on maintaining a healthy weight and metabolic health rather than just fearing fat, as the *capacity* to store fat safely matters immensely.

Adipose tissue acts as an endocrine organ, secreting hormones that influence insulin sensitivity in distant tissues.

Fat tissue is not just storage; it actively sends hormonal signals to your liver, muscles, and brain that affect how you process glucose and fat. Changes in fat mass and function can alter these hormonal signals, impacting your metabolic health.

Central administration of ghrelin directly regulates adipocyte metabolism by increasing glucose utilization and promoting fat storage in white adipose tissue (WAT) while decreasing thermogenesis in brown adipose tissue (BAT), independent of increased food intake.

This research suggests that the hormone ghrelin, when acting on the brain, directly tells fat cells to store more fat and burn less energy, independent of how much you eat. This implies that hormonal signals play a critical role in fat storage efficiency, potentially making weight management harder when ghrelin levels are chronically elevated, regardless of caloric intake.